<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02585492</url>
  </required_header>
  <id_info>
    <org_study_id>Neonatologia-2014-02</org_study_id>
    <nct_id>NCT02585492</nct_id>
  </id_info>
  <brief_title>Effects of Mother Position in Skin-to-skin Contact Newborn on Oxygen Saturation Levels.</brief_title>
  <official_title>Episodes of Decreased Oxygen Saturation in Newborns in Skin-to-skin Contact: Role of Maternal Position After Delivery. A Randomized Clinical Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Red Salud Materno Infantil y del Desarrollo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario 12 de Octubre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Red Salud Materno Infantil y del Desarrollo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the position of the mother in the first two&#xD;
      hours after delivery, while she is in skin to skin contact with your child, influences the&#xD;
      oxygen saturation and/or heart rate of the newborn. In this way it could provide some useful&#xD;
      information for the prevention of seemingly lethal episodes or sudden death of the child&#xD;
      when, following current recommendations is skin to skin contact in the first hours of life.&#xD;
      These episodes are communicating in all developed countries and have caused great concern and&#xD;
      interest in the scientific community. So far we only have information from case series.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The early skin to skin contact between mother and child in the first two hours postpartum is&#xD;
      essential for bonding and breastfeeding. Coinciding with the widespread application of this&#xD;
      procedure in hospitals have been described, in different countries, cases of children who&#xD;
      have suffered episodes of apparent life threatening events (ALTEs) or early sudden deaths&#xD;
      during the same procedure. The cause of these events is unclarified, it is unknown whether&#xD;
      the position of the mother during the first two hours of a child's life affects their&#xD;
      stability.&#xD;
&#xD;
      The investigators's hypothesis is that the frequency of episodes of oxygen saturation less&#xD;
      than 91% in the first 2 hours of life of the newborn is reduced by one third in children&#xD;
      whose mothers are incorporated at 45° above the horizontal plane of the bed compared with&#xD;
      children whose mothers are incorporated to 15º.&#xD;
&#xD;
      This is a multicenter, randomized and controlled study in 10 Spanish hospitals with blind&#xD;
      evaluation. 5866 participants will be enrolled in this study (a total of 1275 children are&#xD;
      required in each arm of the study).&#xD;
&#xD;
      Mother/child (defined as a dyad) will be randomized in two groups:&#xD;
&#xD;
      Group A: head-of-bed elevated 15°. Group B: head-of-bed elevated 45°.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of at least one episode desaturation ≤90%</measure>
    <time_frame>Two first hours after delivery</time_frame>
    <description>The evaluation will be done with a pulse oximeter (non-invasive Radical-7 Signal Extraction PulseCO-Oximeter equipped with Masimo Rainbow SET technology). All the technology used in all hospitals is part of Masimo's SafeyNet system.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1243</enrollment>
  <condition>Neonatal Disorder</condition>
  <arm_group>
    <arm_group_label>head-of-bed elevated 15°</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mother's head-of-bead elevated 15°. Intervention: Head-of-bed elevated 15° during 2 hours after the delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>head-of-bed elevated 45°</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mother's head-of-bead elevated 45°. Intervention: Head-of-bed elevated 45°during 2 hours after delivery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Head-of-bed elevated 15°</intervention_name>
    <description>Head-of-bed elevated 15° during 2 hours after delivery.</description>
    <arm_group_label>head-of-bed elevated 15°</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Head-of-bed elevated 45°</intervention_name>
    <description>Head-of-bed elevated 45° during 2 hours after delivery.</description>
    <arm_group_label>head-of-bed elevated 45°</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Single fetus pregnancy&#xD;
&#xD;
          2. Pregnancy controlled or partially controlled(1)&#xD;
&#xD;
          3. Normal pregnancy or with gestational diabetes treated with diet, high blood pressure&#xD;
             controlled with only a drug as maximum (without preeclampsia)&#xD;
&#xD;
          4. Gestation to term (between 37 weeks to 41 weeks and 6 days of gestational age).&#xD;
&#xD;
          5. Maternal temperature at onset of labor ≤38 degrees Celsius&#xD;
&#xD;
          6. Presence of a companion during the 2 hours after delivery&#xD;
&#xD;
          7. Desire of the mother to perform early skin-to-skin&#xD;
&#xD;
        Exclusion criteria pre-randomization:&#xD;
&#xD;
          1. Consumption of tobacco, alcohol, drugs or any medication with sedative or relaxing(2)&#xD;
             effect or any pathology during pregnancy.&#xD;
&#xD;
          2. Prenatal diagnosis of chromosomal abnormalities or major malformations.&#xD;
&#xD;
          3. Prenatal diagnosis of intrauterine growth restriction with any degree of alteration in&#xD;
             the flow as well as the abnormal small-for-gestational-age fetuses (due to&#xD;
             malformations, intrauterine infection ...).&#xD;
&#xD;
          4. No companion during the first two hours postpartum&#xD;
&#xD;
        Notes:&#xD;
&#xD;
          1. Partially controlled pregnancy: she has the 20 weeks ultrasound but lack the first&#xD;
             and/or third trimester of pregnancy and/or analytical (serology, O'Sullivan test ...).&#xD;
&#xD;
          2. Medicinal products with sedative or relaxing effect: opioids, anticonvulsants,&#xD;
             antipsychotics, benzodiazepines, anxiolytics, hypnotics, antidepressants and sedative&#xD;
             plants.&#xD;
&#xD;
        Post randomization exclusion criteria (at the end of delivery)&#xD;
&#xD;
          1. Related to childbirth:&#xD;
&#xD;
               -  Caesarean section or instrumental delivery (forceps, vacuum)&#xD;
&#xD;
               -  Maternal fever &gt;38 degrees Celsius&#xD;
&#xD;
               -  Mother hemodynamic instability (hypotension, tachycardia, altered level of&#xD;
                  consciousness, poor perfusion, striking pallor)&#xD;
&#xD;
               -  Cord prolapse&#xD;
&#xD;
               -  Signs of fetal distress with lower pH fetal scalp &lt;7.25 or umbilical artery pH&#xD;
                  &lt;7.20&#xD;
&#xD;
               -  Any other obstetrical complication&#xD;
&#xD;
          2. Related mother:&#xD;
&#xD;
               -  Any type of illness&#xD;
&#xD;
               -  Sedatives or relaxants during or after birth(3)&#xD;
&#xD;
          3. Related Newborn (RN)&#xD;
&#xD;
               -  Need for resuscitation measures&#xD;
&#xD;
               -  Major malformation diagnosed intrapartum&#xD;
&#xD;
               -  Apgar ≤7 at one minute, 5 or 10 minutes&#xD;
&#xD;
               -  Presence of clinic(4) before the 10 minutes of life&#xD;
&#xD;
               -  Birth weight &lt;2300 g or&gt;4500 g&#xD;
&#xD;
          4. Interruption of skin contact because the mother present a problem&#xD;
&#xD;
        Notes:&#xD;
&#xD;
        (3) Sedatives or relaxants during or after birth: Pethidine (Dolantina®), scopolamine&#xD;
        (Buscapina®), haloperidol, benzodiazepines and opiates.&#xD;
&#xD;
        (4) Clinic: general discomfort, fever, hypothermia, pallor, mottled skin (cutis marmorata),&#xD;
        cyanosis, petechiae, purpura, lethargy, weakness, poor responsiveness, seizures, tremors,&#xD;
        poor perfusion, maintained tachycardia, bradycardia, hypotension, apnea, tachypnea,&#xD;
        respiratory distress (grunting, nasal flaring, intercostal or subcostal or substernal&#xD;
        retractions, thoracoabdominal dissociation), vomiting, abdominal distesion, etc.&#xD;
&#xD;
        Clarifications:&#xD;
&#xD;
        It can include:&#xD;
&#xD;
          1. Newborns with intrauterine diagnosis of ectasia pyelocaliceal grades I and/or II,&#xD;
             choroid plexus cysts, aberrant right subclavian artery or single umbilical artery&#xD;
             (minor malformations).&#xD;
&#xD;
          2. Newborns whose time broken bag is ≥ to 18 hours provided that they do not present&#xD;
             clinic(4).&#xD;
&#xD;
          3. Newborn with risk of infection without symptoms at birth.&#xD;
&#xD;
          4. Newborn with stained amniotic fluid, born crying, who does not require tracheal&#xD;
             aspiration, or resuscitation and shows no clinical(4) signs during the first 10&#xD;
             minutes after birth.&#xD;
&#xD;
          5. Small for normal fetal gestational age (genetic-family origin)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>259 Days</minimum_age>
    <maximum_age>293 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadia R. García Lara, Dra</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario 12 de Octubre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Severo Ochoa</name>
      <address>
        <city>Leganés</city>
        <state>Madrid</state>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces</name>
      <address>
        <city>Bilbao</city>
        <state>Vizcaya</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Vielha</name>
      <address>
        <city>Lleida</city>
        <zip>25530</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Quirón</name>
      <address>
        <city>Madrid</city>
        <zip>28223</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46022</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 22, 2015</study_first_submitted>
  <study_first_submitted_qc>October 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2015</study_first_posted>
  <last_update_submitted>October 26, 2018</last_update_submitted>
  <last_update_submitted_qc>October 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

